primary dysmenorrhea in female students. Primary dysmenorrhoea
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: willingness and informed consent to participate in the research having a regular menstrual cycle with a duration of 2-6 days and an interval of 21-35 days between periods onset of menstruation before the age of 15 primary dysmenorrhea with a score of 5 or more in the Visual Analogue Scale of pain during two consecutive cycles age 18-25 years being single being Iranian lack of known mental or physical illness (according to the statements of the research participant) absence of gynecological disease (myoma, endometriosis, ovarian cyst , pelvic inflammatory disease, etc.) (according to the statements of the research participant) having a normal sense of smell no history of allergies
Exclusion criteria
Exclusion criteria: not wanting to participating in the study having an allergy to citrus aurantium having an allergy to lavender
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measurable primary outcome: dysmenorrhea pain intensity, measured by the Visual Analogue Scale. Timepoint: Dysmenorrhea pain intensity is measured in 4 cycles, two menstrual cycles before the start of the intervention, and two menstrual cycles after the entry of the study subjects for the intervention. Method of measurement: After defining the groups, each of them is asked to record their pain intensity using the Visual Analogue Scale in the first and second cycles of the intervention. If the pain score is 5 or more than 5 in the first cycle before the intervention, the pain intensity of the people will be measured in the second cycle as well. If they have 5 or more points in two consecutive cycles, people will be included in the study. The pain intensity of people in the second cycle will be evaluated as the pain intensity before the intervention. The intervention of this research was carried out in the third and fourth menstrual cycle of the research units and the effect of inhaled drugs will be investigated. People are asked to record and inform the type, dosage and exact time of use if they take any painkillers at the time of study. In order to ensure that the intervention is performed after the maximum effect of the painkiller and to prevent its effect from interfering with the desired intervention, it is necessary to accurately record the time of use of each painkiller so that the aromatherapy intervention can be performed after the effectiveness of the painkiller is lost. In the third and fourth menstrual cycles of the study subjects, on the first and second days of the cycle, the intervention will be performed and on the third day, the pain intensity of the subjects will be recorded in the presence of the researcher (the subjects will be asked to inform the researcher of the time of menstruation and record their symptoms in the questionnaire). In this study, distilled water will be used as a placebo. Bottles containing distilled water and citrus aurantium an | — |
Countries
Iran (Islamic Republic of)
Contacts
Rasht University of Medical Sciences